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Prevalence of Congenital Adrenal Hyperplasia (CAH) is
not exactly known in the Austria; a number of patients
with CAH might not be diagnosed, especially males. CAH
is in about 95 % of the cases due to a defect in the 21-
hydroxylation (‘classical CAH’). Newborn screening for
CAH, based on the measurement of 17a-hydroxyproges-
terone (17-OHP) was shown to be efficient for diagnosis,
and is part of the newborn screening programme in
Austria since April 2001.
In our study we compared 2 groups of children:
Group A, children born in Styria (a province of Austria),
1992 – 2001, n = 119.001, m 61.256, and f 57.745;
Group B, children born in Styria 2002 – 2011, n =
103.228, m 52.722, and f 50.506
In group A (patients not screened), CAH was diag-
nosed in 8 children (m 4; f 4); 4 of them with simple
virilising (SV) 21-OH deficiency (m 3; f 1) and 4 with
salt wasting (SV) 21-OH deficiency (m 1; f 3).
In group B, 98,7 % of all newborns born in Styria
could be screened by measuring 17-OHP in a dried
blood spot on filter paper. Recall rate was 0,578 %. CAH
was diagnosed in 10 children (m 3: f 7). 8 of them with
SW (m 2; f 6), and 2 with 11b-hydroxylase deficiency
(m 1; f 1).
Whereas group A displayed the expected Mendelian
sex ratio, group B showed a strong female predomi-
nance (m 3; f 7)
Prevalence of CAH was 1:14.875 newborns in group A
(not screened). In group B (newborns screened) preva-
lence was 1:10.132.
If one exclude the 2 patients with 11ß-hydroxylase
deficiency from group B, prevalence of ‘classical CAH’
was 1:14.875 in group A, compared to 1:12.903 in group
B.
These data show that newborn screening for CAH
seems to increase the rate of detection of CAH.
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